DISCONTINUED OPERATIONS (Revenues and Net Income (Loss)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations	$ (22,816)	$ (3,163)
Genetic Assays and Platforms and Patient Testing | Included in assets held for sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	18,584	25,843
Cost of goods sold	12,287	15,187
Gross profit	6,297	10,656
Selling, general and administrative expense	15,187	16,761
Research and development expense	408	648
Impairment of long-lived assets	13,942	0
Operating loss from discontinued operations	(23,240)	(6,753)
(Loss) gain on sale of business	(224)	4,114
Loss from discontinued operations before income taxes	(23,464)	(2,639)
Income tax (benefit) expense	(648)	524
Loss from discontinued operations	$ (22,816)	$ (3,163)